[1]
Gumanti, S.T.A. et al. 2022. Monitoring Efek Samping Obat Antituberkulosis Fase Intensif dan Lanjutan Pasien Dewasa Tuberkulosis di RSUD Kota Bandung. Jurnal Farmasi Indonesia. 12, 1 (Jan. 2022), 86–93. DOI:https://doi.org/10.35617/jfionline.v12i1.52.